Schedule 13G ownership disclosure
KINIKSA PHARMACEUTICALS INTL
Security class unavailable · CUSIP: G52694109
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,419,103
- Percent of class
- 5.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-117745
- Form type
- SC 13G
- Filer
- Kiniksa Pharmaceuticals International, plc
- CIK
- CIK 1730430
- Filed
- Nov 13, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership